In an article titled “Empagliflozin’s effects independent of CVD risk factors,” published Sept. 27, 2017, the proportion of patients who achieved control of HbA1c, LDL cholesterol, and blood pressure at baseline in the empagliflozin group was misstated. It was 12.6%.

Ads

You May Also Like

Serotonergic dysfunction documented in hoarding disorder

AT ANXIETY AND DEPRESSION CONFERENCE 2017 SAN FRANCISCO (FRONTLINE MEDICAL NEWS) – Hoarding disorder ...